{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:22:26Z","timestamp":1788524546042,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.humpath.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:24:19Z","timestamp":1620735859000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer"],"prefix":"10.1016","volume":"114","author":[{"given":"Naoki","family":"Mochidome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuyuki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-1890","authenticated-orcid":false,"given":"Ryota","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Aishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-1182","authenticated-orcid":false,"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.05.001_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1440-1827.2005.01816.x","article-title":"Proposal of histological criteria for intraepithelial atypical\/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement","volume":"55","author":"Zen","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.25786","article-title":"Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?","volume":"56","author":"Rocha","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2021.05.001_bib4","series-title":"WHO classification of tumours of the digestive system","first-page":"266","article-title":"Carcinoma of the gallbladder and extrahepatic bile ducts","author":"Klimstra","year":"2010"},{"key":"10.1016\/j.humpath.2021.05.001_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/PAS.0b013e318262787c","article-title":"Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are \u22651.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib6","series-title":"WHO classification of tumours of the digestive system","first-page":"265","article-title":"Tumours of the gallbladder and extrahepatic bile duct","author":"Klimstra","year":"2019"},{"key":"10.1016\/j.humpath.2021.05.001_bib7","series-title":"AFIP atlas of tumor pathology series 4","article-title":"Tumors of the gallbladder, extrahepatic bile ducts and vaterian system","author":"Albores-Saveedra","year":"2015"},{"key":"10.1016\/j.humpath.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12253-013-9710-5","article-title":"Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.humpath.2021.05.001_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0046-8177(96)90109-4","article-title":"p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study","volume":"27","author":"Wistuba","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02940312","article-title":"Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas","volume":"13","author":"Chang","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.humpath.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13651820410025110","article-title":"Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers","volume":"6","author":"Hidalgo Grau","year":"2004","journal-title":"HPB (oxford)"},{"key":"10.1016\/j.humpath.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12253-014-9886-3","article-title":"Pathology of gallbladder carcinoma: current understanding and new perspectives","volume":"21","author":"Bal","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.humpath.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.humpath.2009.01.024","article-title":"IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas","volume":"40","author":"Riener","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.12.028","article-title":"Insulin-like growth factor II mRNA-binding protein3 (IMP3) is a marker that predicts presence of invasive in papillary biliary tumors","volume":"62","author":"Sasaki","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib15","series-title":"WHO classification of tumours of the digestive System","first-page":"304","article-title":"Intraductal neoplasms of the pancreas","author":"Hruban","year":"2010"},{"key":"10.1016\/j.humpath.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2407-10-59","article-title":"Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival","volume":"10","author":"Schaeffer","year":"2010","journal-title":"BMC Canc"},{"key":"10.1016\/j.humpath.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0b013e3182189223","article-title":"Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma","volume":"35","author":"Wachter","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.001_bib19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.humpath.2012.12.020","article-title":"Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm","volume":"44","author":"Morimatsu","year":"2013","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:40Z","timestamp":1758645520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":19,"alternative-id":["S0046817721000745"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}